Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease - PubMed (original) (raw)
doi: 10.1016/j.neuropsychologia.2008.02.008. Epub 2008 Feb 14.
K E Pike, D Darby, P Maruff, G Savage, S Ng, U Ackermann, T F Cowie, J Currie, S G Chan, G Jones, H Tochon-Danguy, G O'Keefe, C L Masters, C C Rowe
Affiliations
- PMID: 18343463
- DOI: 10.1016/j.neuropsychologia.2008.02.008
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
V L Villemagne et al. Neuropsychologia. 2008.
Abstract
Approximately 30% of healthy persons aged over 75 years show Abeta deposition at autopsy. It is postulated that this represents preclinical Alzheimer's disease (AD). We evaluated the relationship between Abeta burden as assessed by PiB PET and cognitive decline in a well-characterized, non-demented, elderly cohort. PiB PET studies and cognitive tests were performed on 34 elderly participants (age 73+/-6) from the longitudinal Melbourne Healthy Aging Study (MHAS). Subjects were classified as being cognitively 'stable' or 'declining' by an independent behavioural neurologist based on clinical assessment and serial word-list recall scores from the preceding 6-10 years. Decline was calculated from the slope of the word-list recall scores. Abeta burden was quantified using Standardized Uptake Value normalized to cerebellar cortex. Ten subjects were clinically classified as declining. At the time of the PET scans, three of the declining subjects had mild cognitive impairment, one had AD, and six were declining but remained within the normal range for age on cognitive tests. Declining subjects were much more likely to show cortical PiB binding than stable subjects (70% vs. 17%, respectively). Neocortical Abeta burden correlated with word-list recall slopes (r=-0.78) and memory function (r=-0.85) in the declining group. No correlations were observed in the stable group. Abeta burden correlated with incident memory impairment and the rate of memory decline in the non-demented ageing population. These observations suggest that neither memory decline nor Abeta deposition are part of normal ageing and likely represent preclinical AD. Further longitudinal observations are required to confirm this hypothesis.
Similar articles
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Villemagne VL, et al. Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8. Lancet Neurol. 2013. PMID: 23477989 - Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC. Pike KE, et al. Brain. 2007 Nov;130(Pt 11):2837-44. doi: 10.1093/brain/awm238. Epub 2007 Oct 10. Brain. 2007. PMID: 17928318 - Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA; 18F-AV-1451-A05 investigators. Pontecorvo MJ, et al. Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334. Brain. 2017. PMID: 28077397 Free PMC article. - Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
Villemagne VL, Rowe CC. Villemagne VL, et al. J Alzheimers Dis. 2013;33 Suppl 1:S349-59. doi: 10.3233/JAD-2012-129034. J Alzheimers Dis. 2013. PMID: 22710919 Review. - PET imaging of brain amyloid in dementia: a review.
Quigley H, Colloby SJ, O'Brien JT. Quigley H, et al. Int J Geriatr Psychiatry. 2011 Oct;26(10):991-9. doi: 10.1002/gps.2640. Epub 2010 Dec 28. Int J Geriatr Psychiatry. 2011. PMID: 21905095 Review.
Cited by
- Pattern and predictability in memory formation: from molecular mechanisms to clinical relevance.
Philips GT, Kopec AM, Carew TJ. Philips GT, et al. Neurobiol Learn Mem. 2013 Oct;105:117-24. doi: 10.1016/j.nlm.2013.05.003. Epub 2013 May 28. Neurobiol Learn Mem. 2013. PMID: 23727358 Free PMC article. Review. - Neuropathological approaches to cerebral aging and neuroplasticity.
Jellinger KA, Attems J. Jellinger KA, et al. Dialogues Clin Neurosci. 2013 Mar;15(1):29-43. doi: 10.31887/DCNS.2013.15.1/kjellinger. Dialogues Clin Neurosci. 2013. PMID: 23576887 Free PMC article. Review. - Adulthood cognitive trajectories over 26 years and brain health at 70 years of age: findings from the 1946 British Birth Cohort.
James SN, Nicholas JM, Lu K, Keshavan A, Lane CA, Parker T, Buchanan SM, Keuss SE, Murray-Smith H, Wong A, Cash DM, Malone IB, Barnes J, Sudre CH, Coath W, Modat M, Ourselin S, Crutch SJ, Kuh D, Fox NC, Schott JM, Richards M. James SN, et al. Neurobiol Aging. 2023 Feb;122:22-32. doi: 10.1016/j.neurobiolaging.2022.10.003. Epub 2022 Oct 18. Neurobiol Aging. 2023. PMID: 36470133 Free PMC article. - Reference region automatic extraction in dynamic [(11)C]PIB.
Ikoma Y, Edison P, Ramlackhansingh A, Brooks DJ, Turkheimer FE. Ikoma Y, et al. J Cereb Blood Flow Metab. 2013 Nov;33(11):1725-31. doi: 10.1038/jcbfm.2013.133. Epub 2013 Aug 7. J Cereb Blood Flow Metab. 2013. PMID: 23921900 Free PMC article. - Amyloid imaging and memory change for prediction of cognitive impairment.
Resnick SM, Sojkova J. Resnick SM, et al. Alzheimers Res Ther. 2011 Jan 31;3(1):3. doi: 10.1186/alzrt62. Alzheimers Res Ther. 2011. PMID: 21345176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical